Dataset Information

Evaluation and optimization of a conventional SPCE for FMD post-vaccination monitoring.

ABSTRACT: BACKGROUND:Foot-and-mouth disease (FMD) can be controlled by either stamping out or vaccination, a choice which depends on both the economic importance of the livestock sector as well as the disease status. In FMD-free countries with vaccination, such as Korea, vaccination programs should guarantee prevention against transmission of FMD. Monitoring of vaccination programs is also essential for ensuring sufficient coverage that will limit the transmission of FMDV. There are several methods to screen FMD virus (FMDV) structural protein (SP) antibodies including SPCE (Solid-phase competitive ELISA), LPBE (Liquid-phase blocking ELISA), and VNT (Virus neutralization test). Among these, SPCE is widely used for serological monitoring since VNT-the gold standard method-has certain practical limitations, such as high costs in terms of time and labor. However, whether SPCE can ensure the vaccination status of individual animals and whole farms is unclear. In this study, SPCE, LPBE and VNT were compared with respect to correlation with each other and sensitivity at commercial pig farms. RESULTS:The positive results obtained by PrioCHECK SPCE differed from those obtained by LPBE and VNT. The sensitivity of SPCE relative to those of the other tests was fairly low. The raw data of SPCE were most highly correlated with those of VNT with XJ strain, while their positivity and negativity were most highly correlated with LPBE. The results of ROC analysis proposed new cut-off for PrioCHECK SPCE higher than the previous 50% inhibition. CONCLUSIONS:The high false positive rate of PrioCHECK SPCE suggested that high seropositivity by SPCE may not guarantee a true vaccination coverage. Adjusting the cut-off percentage (%) inhibition value for SPCE is needed to address this problem, and it is highly recommended that routine FMDV serological monitoring programs using PrioCHECK SPCE should be combined with alternative methods such as LPBE or VNT.

SUBMITTER: Kang YL

PROVIDER: S-EPMC6260702 | biostudies-other | 2018 Nov

REPOSITORIES: biostudies-other

ACCESS DATA

Publications

Evaluation and optimization of a conventional SPCE for FMD post-vaccination monitoring.

Kang Yeong-Lim YL Jeong Ji-Yun JY Choi Hwi-Yeon HY Zhang Yanhong Y Liu Yumei Y Lee Ho-Jong HJ Choi Jong-Chul JC Lee So-Hyun SH Lee Beom-Joo BJ Lee Sang-Won SW Lee Joong-Bok JB Cho Ki-Hyun KH Park Seung-Yong SY

BMC veterinary research 20181128 1

<h4>Background</h4>Foot-and-mouth disease (FMD) can be controlled by either stamping out or vaccination, a choice which depends on both the economic importance of the livestock sector as well as the disease status. In FMD-free countries with vaccination, such as Korea, vaccination programs should guarantee prevention against transmission of FMD. Monitoring of vaccination programs is also essential for ensuring sufficient coverage that will limit the transmission of FMDV. There are several method ...[more]

PMID: 30486820

Similar Datasets

Project description:In South Korea, domestic cattle, pigs, and goats were subjected to mandatory foot-and-mouth disease (FMD) vaccination and year-round serosurveillance since 2011. In 2020, approximately USD 95 million was spent solely for FMD vaccine purchase for 59 million livestock, and 1.25 million samples were tested to estimate the population immunity and demonstrate the absence of virus circulation. As the FMD vaccination program was revised in 2018, the post-vaccination monitoring (PVM) was designed to evaluate the effectiveness of the vaccine program of three vaccines approved for routine use. To this end, monitoring post-vaccination immunity has been conducted by collecting 35,626 serum samples at 28 days post-vaccination following regular national vaccinations, which were carried out in April and in October in 2020. The design of the serological test for PVM was specially targeted at particular livestock groups, including dairy cattle, goats, and beef cattle aged 6-12 months, which were generally estimated to have a low expected seroprevalence. The risk factors had also been identified, considering the increased likelihood of infection in a particular location, herd size, and husbandry system applied in a targeted sample collection. Serum sample collection and SP-O and NSP antibody tests were performed by local veterinary laboratories using commercially available ELISAs. The current FMD vaccination program, which was performed twice a year following the regimen of primary vaccination and boost, resulted in over 80% population immunity. The seroprevalence monitored after the vaccination in fall was higher than the one studied in spring except in pigs. It was demonstrated that the seroprevalence of risk-based targeted samples ranged from 93.8 to 100% in cattle, 63.2 to 100% in pigs, and 20.0 to 100% in goats. Of note is the area near the North Korean borders which showed a relatively low seroprevalence among the targeted regions, and no NSP sero-positive reactor was detected in this region. When subpopulation immunity at the individual level was assessed, the seroprevalence in young cattle stock was slightly lower (95.8%) than that of adults (98.4%). In conclusion, the FMD vaccination campaign has been successfully implemented in Korea, and the PVM can be a supplementary program for massive routine surveillance in terms of providing timely information needed both to estimate population immunity and to properly target "risk-based surveillance."

Project description:Waning humoral immunity after mRNA vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a significant problem for public health. Breakthrough infection in hospitals over several months after vaccination has not been fully characterized, especially against the delta (B.1.617.2) variant. Here, we describe an outbreak in our hospital in September of 2021, mainly through serological evaluation of the breakthrough infection. This retrospective observational study was done at an emergency and acute care hospital with 204 beds and 486 staff members where most staff members (92.6%) had had their second BNT162b2 vaccination by May of 2021. The peri-infection anti-spike RBD protein IgG (anti-S IgG) titers (lowest values between 11 days before and 7 days after onset or diagnosis) of serum samples from the breakthrough-infected persons were quantified. We also logarithmically estimated the anti-S IgG titers during the exposure period in September of uninfected staff members from their samples collected in May and December 2021. Whole-genome sequencing was done on obtained samples. In this outbreak, twelve persons (ten inpatients and two staff members) were diagnosed with SARS-CoV-2 infection by Loop-Mediated Isothermal Amplification (LAMP) or RT-PCR, eight of whom had been vaccinated twice. Peri-infection anti-S IgG titers could be determined in seven of the eight breakthrough cases, with a geometric mean titer (GMT) of 1,034 AU/ml (95% confidence interval [CI], 398 to 2,686). Among 289 uninfected staff members with data from the two sampling points, the GMT of the estimated anti-S IgG titers during the exposure period in 51 staff members, who were working at the outbreak ward and potentially exposed but uninfected, and 238 other unexposed staff members were 1,458 AU/ml (95% CI, 1,196 to 1,777) and 1,628 AU/ml (95% CI, 1,500 to 1,766), respectively. All viruses from the eight samples for which whole-genome sequencing was available were identified as delta variants. Of the infected persons, one remained asymptomatic throughout the course of treatment, and eleven had an illness of mild to moderate severity, including ten who received monoclonal antibody cocktail (Casirivimab/imdevimab) therapy. Measurement and estimation of anti-spike antibody levels after SARS-CoV-2 vaccination would be helpful for evaluating the risk of breakthrough infection and for determining the necessity of booster vaccination.

Project description:Glycolysis of post-consumer polyethylene terephthalate (PET) waste is a promising chemical recycling technique, back to the monomer, bis(2-hydroxyethyl) terephthalate (BHET). This work presents sodium methoxide (MeONa) as a low-cost catalyst for this purpose. BHET product was confirmed by gas chromatography-mass spectrometry (GCMS), Nuclear Magnetic Resonance (NMR) Spectroscopy, melting point, and Differential Scanning Calorimetry (DSC). It was shown, not surprisingly, that PET conversion increases with the glycolysis temperature. At a fixed temperature of 190 °C, the response surface methodology (RSM) based on the Box-Behnken design was applied. Four independent factors, namely the molar ratio of PET: MeONa (50-150), the molar ratio of ethylene glycol to PET (EG: PET) (3-7), the reaction time (2-6 h), and the particle size (0.25-1 mm) were studied. Based on the experimental results, regression models as a function of significant process factors were obtained and evaluated by analysis of variance (ANOVA), to predict the depolymerization performance of MeONa in terms of PET conversion. Coefficient of determination, R2 of 95% indicated the adequacy for predicted model. Afterward, the regression model was validated and optimized within the design space with a prediction of 87% PET conversion at the optimum conditions demonstrating a deviation of less than 5% from predicted response. A van 't Hoff plot confirmed the endothermic nature of the depolymerization reaction. The ceiling temperature (TC = 160 °C) was calculated from Gibbs' free energy. A kinetic study for the depolymerization reaction was performed and the activation energy for MeONa was estimated from the Arrhenius plot (EA = 130 kJ/mol). The catalytic depolymerization efficiency of MeONa was compared under similar conditions with widely studied zinc acetate and cobalt acetate. This study shows that MeONa's performance, as a glycolysis catalyst is promising; in addition, it is much cheaper and environmentally more benign than heavy metal salts. These findings make a valuable contribution towards the chemical recycling of post-consumer PET waste to meet future recycling demands of a circular economy.

Project description:Purpose To evaluate T and B cell subsets and IgG antibodies in response to SARS-CoV-2 post COVID-19 vaccination. Methods A total of 50 healthy adults (18–60 years) receiving anti-SARS-CoV-2 vaccination (COVISHIELD) were recruited for the study. Blood samples were collected from participants at 3 time points; just before vaccination (Visit 0, V0), just before booster dose (Visit 1, V1) and 6th month after 1st dose (Visit 2, V2). Peripheral blood mononuclear cell isolation was done and evaluated for T and B cell subsets by Flow cytometry. Quantitative determination of IgG antibodies to SARS-CoV-2 was done by Chemiluminescence immunoassay in all samples. Final data for all three visits was available for 37 participants who remained healthy. Ethics approval was obtained from Medanta Institution of Ethics Committee vide MICR No. 1290/2021 dated 24th May 2021. Results Mean age of the participants was 34.6 ± 5.7 years (Range: 24–45 years). Highly significant improvement in SARS-CoV-2 IgG levels was observed after each visit {Mean IgG: (V0 v/s. V1: 133.8 ± 339.2AU/ml v/s. 434.5 ± 519.2AU/ml; p-value = 0.003) and V0 v/s. V2: 133.8 ± 339.2AU/ml v/s. 420.9 ± 394.2AU/ml; p-value = 0.002) Between visits 0 and 1, the mean value for CD4 Naïve T cells showed significant increase, while CD4 central memory (CM) T cells showed significant decrease. Between visits 0 and 2 the mean values for CD4 Naïve T cells, CD8 Naïve T cells and Pre germinal centre (Pre GC) B cells showed significant increase. During the same period the mean values for CD4CM, CD8 effector memory (EM) and CD8 CM T cells showed significant decrease. Conclusion It is concluded that both, humoral and cellular immunity, play an important role in maintaining immunity against COVID-19 infection, following COVISHIELD vaccination. Moreover, in subjects with normalisation of antibody levels post vaccination, persistence of T cell subsets may still offer some immunity.

Dataset Information

Evaluation and optimization of a conventional SPCE for FMD post-vaccination monitoring.

Publications

Evaluation and optimization of a conventional SPCE for FMD post-vaccination monitoring.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets